# Inscinstech Co., Ltd.(China)

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inscinstech-co-ltd-china

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.inscinstech.com.cn
- Latest round: Series C (Jan 18, 2025)
- Investors on record: 10

## About

Established in 2017 and based in Suzhou, China, Inscinstech operates as a biopharmaceutical CMC (chemical manufacturing and control) process tools solutions provider that focuses on bioseparation technology R&D. It has a marketing, service, and R&D center located in the USA. The company's manufacturing bases passed ISO9001 quality management system certification and GJB9001C-2017 weapons and equipment quality management system certification. In addition, it has established branches in Beijing, Shanghai, Guangzhou, Wuhan, Chengdu, Hangzhou and other places. In January 2025, it closed a series C funding.

The company provides biological isolation and purification solutions for the pharmaceutical industry. Its products include Unique AutoPure protein purification system, Unique AutoOligo large-scale nucleic acid synthesizer, and Unique AutoMCD nano-plasmid assembly system. Unique AutoPure protein purification system can be applied to monoclonal antibodies monoclonal antibodies, recombinant proteins, vaccines and biochemical fields. Unique AutoMCD is a nanoparticle automated assembly system, and it has patented dosing-type liquid delivery technology and pressure-assisted sputtering mixing technology. Inscinstech Co., Ltd.(China)  generates revenue by providing biopharmaceutical CMC process tools and solutions, including sales of laboratory instruments and process equipment, as well as technical services to clients in the biopharmaceutical, life science, and related industries. The company will use the series C funding for the research and development of the biotechnology CMC process tool product pipeline and the expansion of production capacity.

## Funding rounds

- Series C, Jan 18, 2025 — Oriza Holdings, Shandong High-tech Investment Corporation, China Merchants Capital
- Series B, Jan 4, 2023 — Qiming Venture Partners, Shandong High-tech Investment Corporation, Addor Capital, MPC, Jinkong Qiyuan Capital, Qianhai Infrastructure Investment, Singapore ESCO
- Series A, Oct 29, 2021 — Addor Capital, MPC, Dynamic Capital

## Investors

- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A, Series B
- MPC — Series A, Series B
- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Shandong High-tech Investment Corporation (https://capitalatlas.ai/funds/shandong-high-tech-investment-corporation) — Series B, Series C
- Jinkong Qiyuan Capital (https://capitalatlas.ai/funds/jinkong-qiyuan-capital) — Series B
- Qianhai Infrastructure Investment — Series B
- Singapore ESCO — Series B
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series C
- China Merchants Capital (https://capitalatlas.ai/funds/china-merchants-capital) — Series C